Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators: Substrates, methods, and clinical experience

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 9, 2004, Pages 1292-1305

  Sweeney, Michael O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITACHYCARDIA PACING; ARTIFICIAL HEART PACEMAKER; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; QUALITY OF LIFE; REENTRY ARRHYTHMIA; REVIEW;

AGED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CORONARY ARTERIOSCLEROSIS; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MALE; PATIENT SELECTION; QUALITY OF LIFE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 4644302398     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00622.x     Document Type: Review

References (78)

1. Fisher JD, Mehra R, Furman S. Termination of ventricular tachycardia with bursts of rapid ventricular pacing. Am J Cardiol 1978; 41:94-102.
2. Josephson ME. Clinical cardiac electrophysiology: Techniques and interpretations. 3rd ed. Philadelphia: Lippincott, Williams and Wilkins; 2002.
3. Josephson ME, Almendral JM, Buxton AE, et al. Mechanisms of ventricular tachycardia. Circulation 1987; 74:41-47.
4. de Bakker JMT, van Capelle FJL, Janse MJ, et al. Reentry as a cause of ventricular tachycardia among patients with chronic ischemic heart disease: Electrophysiologic and anatomic correlation. Circulation 1988; 77:589-606.
5. de Bakker JM, van Capelle FJL, Janse MJ, et al. Macroreentry in the infarcted human heart: Mechanism of ventricular tachycardias with a focal activation pattern. J Am Coll Cardiol 1991; 18:1005-1014.
6. Pogwizd SM, Hoyt RH, Saffitz JE, et al. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation 1992; 86:1872-1887.
7. Gardner PI, Ursell PC, Fenoglio JJ Jr., et al. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985; 72:592-611.
8. de Bakker JMT, van Capelle FJL, Janse MJ, et al. Slow conduction in the infarcted human heart: "zigzag" course of activation. Circulation 1993; 88:915-926.
9. Wilber DJ, Kopp DE, Glascock DN, et al. Catheter ablation of the mitral isthmus for ventricular tachycardia asssociated with inferior infarction. Circulation 1995; 92:3481-3489.
10. Roy D, Marchand E, Theroux P, et al. Long-term reproducibility and significance of provocable ventricular arrhythmias after myocardial infarction. J Am Coll Cardiol 1986; 8:32-37.
11. Brembilla-Perrot B, Houriez P, Claudon O, et al. Long-term reproducibility of ventricular tachycardia induction with electrophysiological testing in patients with coronary heart disease and depressed left ventricular ejection fraction. PACE 2000; 23:47-53.
12. Lahiri A, Balasubramian V, Rafferty EB. Sudden death during ambulatory monitoring. Br Med J 1977; 1:1676-1678.
13. Gradman AH, Bell PA, DeBusk RF. Sudden death during ambulatory monitoring. Circulation 1977; 55:210-211.
14. Pratt CM, Francis MJ, Luck JC, et al. Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events. J Am Coll Cardiol 1982; 2:789-797.
15. Raitt MH, Dolack GL, Kudenchuk PJ, et al. Ventricular arrhythmias detected after transvenous defibrillator implantaiton among patients with a clinical history ofonly ventricular fibrillation: Implication for use of implantable defibrillator. Circulation 1995; 91:1996-2001.
16. Roberts WC, Siegel RJ, BM M. Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients. Am J Cardiol 1987; 60:1304-1315.
17. de Bakker JM, van Capelle FJ, Janse MJ, et al. Fractionated electrograms in dilated cardiomyopathy: Origin and relation to abnormal conduction. J Am Coll Cardiol 1996; 27:1071-1078.
18. Wu TJ, Ong JJC, Hwang C, et al. Characteristics of wavefronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: Role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 1998; 32:187-196.
19. Cassidy DM, Vassallo JA, Miller JM, et al. Endocardial catheter mapping in humans in sinus rhythm: Relationship to underlying heart disease and ventricular arrhythmias. Circulation 1986; 73:645-652.
20. Delacretaz E, Stevenson WG, Ellison KE, et al. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol 200; 11:11-17.
21. Pogwizd SM, McKenzie JP, Gain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 1998; 98:2404-2414.
22. Vermeulen JT, Tan HL, Rademaker H, et al. Electrophysiologic and extracellular ionic changes during acute ischemia in the failing and normal rabbit myocardium. J Mol Cell Cardiol 1996; 28:123-131.
23. Fisher JD, Kim SG, Matos JA, et al. Comparative effectiveness of pacing techniques for termination of well-tolerated sustained ventricular tachycardia. PACE 1983; 65:915-922.
24. Callans J, Hook BG, Josephson ME. Comparison of resetting and entrainment of uniform sustained ventricular tachycardia. Further insights into the characteristics of the excitable gap. Circulation 1993; 87:1229-1238.
25. Sharma V, DeGroot PJ, Wathen MS. Incidence and characteristics of Type-2 breaks in response to antitachycardia pacing therapy in implantable cardioverter defibrillator patients. J Cardiovasc Electrophysiol 2003; 14:1156-1162.
26. Callans DJ, Marchlinksi FE. Characterization of spontaneous termination of sustained ventricular tachycardia associated with coronary artery disease. Am J Cardiol 1991; 67:50-54.
27. Fisher JD, Johnston DR, Kim SG, et al. Implantable pacers for tachycardia termination: Stimulation techniques and long-term efficacy. PACE 1986; 9:1325-1333.
28. Gillis AM, Leitch J, Sheldon RS, et al. A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease. Am J Cardiol 1993; 72:1146-1151.
29. Calkins H, El-Atassi R, Kalbfleisch S, et al. Comparison of fixed burst versus decremental burst pacing for termination of ventricular tachycardia. PACE 1993; 16:26-32.
30. Kantoch MJ, Green MS, Tang AS. Randomized cross-over evaluation of two adaptive pacing algorithms for the termination of ventricular tachycardia. PACE 1993; 16:1664-1672.
31. Hamill SC, Packer DL, Stanton MS, et al. and the Multicenter PCD Investigator Group. Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. PACE 1995; 18:3-10.
32. Fisher JD, Zhang Z, Kim SG, et al. Comparison of burst pacing, autodecremental (ramp) pacing, and universal pacing for termination of ventricular tachycardia. Archives des Maladies du Coeur et des Vaisseaux 1996; 89:135-139.
33. Newman D, Dorian P, Hardy J. Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol 1993; 21:1413-1418.
34. Schaumann A, Poppinga A, von zur Muehlen F, et al. Antitachycardia pacing for ventricular tachycardias above and below 200 beats/min: A prospective study for ramp versus can mode. (abstract) PACE 1997; 20:1108.
35. Peters RW, Zhang X, Gold MR. Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: The importance of the patient's sex. PACE 2001; 24:70-74.
36. Nasir N, Pacifics A, Doyle TK, et al. Spontaneous ventricular tachycardia treated by antitachycardia pacing. Cadence Investigators. Am J Cardiol 1997; 790:820-822.
37. Schaumann A, von zur Muhlen F, Herse B, et al. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients. Circulation 1998; 97:66-74.
38. Wathen MS, Sweeney MO, DeGroot P, et al. for the PainFREE Rx Investigators. Shock reduction using antitachycardia pacing for rapid spontaneous ventricular tachycardia in patients with coronary artery disease. Circulation 2001; 104:796-801.
39. Wathen MS, Sweeney MO, Khalighi K, et al. Prospective, randomized comparison of shock versus antitachycardia pacing for fast ventricular tachycardia (188-250 bpm) in ICD patients. In: North American Society of Pacing and Electrophysiology (NASPE) Annual Scientific Sessions; 2003; Washington, DC; 2003.
40. Fries R, Heisel A, Nikoloudakis N, et al. Antitachycardia pacing in patients with implantable cardioverter-defibrillators: Inverse circadian variation of therapy success and acceleration. Am J Cardiol 1997; 80:1487-1489.
41. Kouakam C, Lauwerier B, Klug B, et al. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators. Am J Cardiol 2003; 92:26-32.
42. Volosin KJ, Khalighi K, Machado C, et al. Ejection fraction predicts success of antitachycardia pacing for fast ventricular tachycardia. Circulation 2003; 108:IV-544.
43. Krater L, Lamp B, Heintze J, et al. Influence of antitachy pacing location on the efficacy of ventricular tachycardia termination. J Am Coll Cardiol 2002; 39:124A.
44. Lozano IF, Higgins S, Hummel J, et al. The efficacy of simultaneous right and left ventricular antitachycardia pacing (BiV ATP) in heart failure patients with an AICD indication improves with time. (abstract) PACE 2003; 26:984.
45. Guerra J, Wu J, Miller JM, et al. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003; 14:1245-1247.
46. Medina-Ravell VA, Lankipalli RS, Yan GX, et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization. Circulation 2003; 107:740-746.
47. Sears SF, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: Medical and psychosocial considerations for research and clinical care. Clin Cardiol 2003; 26:107-111.
48. Schron EB, Exner DV, Yao Q, et al. for the AVID Investigators. Quality of life in the antiarrhythmics versus implantable defibrillators trial. Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105:589-594.
49. Namerow PB, Firth BR, Heywood GM, et al. for the CABG Patch Trial Investigators and Coordinators. Quality of life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG Patch Trial. PACE 1999; 22:1305-1313.
50. Irvine J, Dorian P, Baker B, et al., for the CIDS Investigators. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002; 144:282-289.
51. Exner DV. Quality of life in patients with life threatening arrhythmias: Does choice of therapy make a difference? Am Heart J 2002; 144:208-211.
52. Sears SF, Todaro JF, Urizar G, et al. Assessing the psychosocial impact of the ICD: A national survey of implantable cardioverter defibrillator health care providers. PACE 2000; 23:939-945.
53. Leitch JW, Gillis AM, Wyse DG, et al. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol 1991; 18:145-151.
54. Wathen MS, Khaligi K, Voloson KJ, et al., for the PainFREE Rx II Investigators. Antitachycardia pacing of fast ventricular tachycardia improves quality of life in implantable cardiac defibrillator patients. Circulation 2003; 108:IV-615.
55. Wilkoff B, Hess M, Young JD, et al., on behalf of the MIRACLE ICD Investigators. Differences in ICD utilization by primary and secondary prevention patients with cardiac resynchronization therapy indication. (abstract) PACE 2003; 26:972.
56. Russo AM, Hsia H, Callans D, et al. Importance of avoiding nominal programming to prevent inappropriate implantable cardioverter defibrillator shocks. J Am Coll Cardiol 2002; 39:79A.
57. Bansch D, Castrucci M, Bocker D, et al. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction, and significance. J Am Coll Cardiol 2000; 36:557-565.
58. Bansch D, Brunn J, Castrucci M, et al. Syncope in patients with implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol 1998; 31:608-615.
59. Grimm W, Flores BF, Marchlinski FE. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillators. Am J Cardiol 1993; 71:1415-1418.
60. Olatidoye AG, Verroneau J, Kluger J. Mechanisms of syncope in implantable cardioverter-defibrillator recipients who receive device therapies. Am J Cardiol 1998; 82:1372-1376.
61. Curtis AB, Conti JB, Tucker KJ, et al. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1995; 26:180-184.
62. Crozier IG, Ikram H, Niholls MG. Hemodynamic and hormone changes during induced ventricular tachycardia secondary to coronary artery disease. Am J Cardiol 1989; 63:618-621.
63. Singer I, Dawn B, Edmonds H Jr., et al. Syncope is predicted by neuromonitoring in patients with ICDs. PACE 1999; 22:216-222.
64. Samet P. Hemodynamic sequelae of cardiac arrhythmias. Circulation 1973; 47:399-408.
65. Smith M, Kinugawa T, Dibner-Dunlap ME. Reflex control of sympathetic activity during ventricular tachycardia in dogs. Circulation 1996; 93:1033-1042.
66. Smith ML, Joglar JA, Wasmund SL, et al. Reflex control of sympathetic activity during simulated ventricular tachycardia in humans. Circulation 1999; 100:628-634.
67. Hamdan MH, Joglar JA, Page RL, et al. Baroreflex gain predicts blood pressure recovery during simulated ventricular tachycardia in humans. Circulation 1999; 100:381-386.
68. Steinbach KK, Merl O, Frohner K, et al. Hemodynamics during ventricular tachyarrhythmias. Am Heart J 1994; 127:1102-1106.
69. Huikuri HV, Zaman L, Castellanos A, et al. Changes in spontaneous sinus node rate as an estimate of cardiac autonomic tone during stable and unstable ventricular tachycardia. J Am Coll Cardiol 1989; 13:646-656.
70. Hamer AWF, Rubin SA, Peter T, et al. Factors that predict syncope during ventricular tachycardia in patients. Am Heart J 1984; 107:997-1005.
71. Saksena S, Ciccone JM, Craelius W, et al. Studies on left ventricular function during sustained ventricular tachycardia. J Am Coll Cardiol 1984; 4:501-508.
72. Kou WH, Calkins H, Lewis RR, et al. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med 1991; 115:942-945.
73. Weber M, Block M, Bansch D, et al. Antitachycardia pacing for rapid VT during ICD charging: A method to prevent ICD shocks. PACE 2001; 24:345-351.
74. Brown ML, Sarkar S. Discrimination of VT from VF by stability of ventricular electrogram morphology. (Abstract) PACE 2003; 26:988.
75. Peinado R, Almendral J, Rius T, et al. Randomized, prospective comparison of four burst pacing algorithms for spontaneous ventricular tachycardia. Am J Cardiol 1998; 82:1422-1425.
76. Prystowsky EN, Klein GJ. Cardiac Arrhythmias. An integrated approach for the clinician. New York: McGraw-Hill, Inc, 1994.
77. Stevenson WG. Ventricular tachycardia after myocardial infarction. J Cardiovasc Electrophysiol 1995; 6:942-950.
78. Sweeney MO, Guy ML, McGovern B, et al. Success of implantable cardioverter-defibrillator antitachycardia pacing algorithms for spontaneous sustained ventricular tachycardia is not dependent on local bipolar electrogram morphology. (abstract) Circulation 1996; 94:I-321.